Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amylyx Pharmaceuticals Inc (AMLX – Research Report), BioMarin Pharmaceutical (BMRN – Research Report) and DENTSPLY SIRONA (XRAY – Research Report). Amylyx Pharmaceuticals Inc (AMLX) In a report issued on August 24, Marc Goodman from SVB Securities maintained a Buy rating on Amylyx Pharmaceuticals Inc, with a price target of $31.00. The company's shares closed last Friday at $26.31. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-amylyx-pharmaceuticals-inc-amlx-biomarin-pharmaceutical-bmrn-and-dentsply-sirona-xray?utm_source=advfn.com&utm_medium=referral
DENTSPLY SIRONA (NASDAQ:XRAY)
Gráfico Histórico do Ativo
De Nov 2022 até Dez 2022 Click aqui para mais gráficos DENTSPLY SIRONA.
DENTSPLY SIRONA (NASDAQ:XRAY)
Gráfico Histórico do Ativo
De Dez 2021 até Dez 2022 Click aqui para mais gráficos DENTSPLY SIRONA.